2,623
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Glucomannan hydrolysate (GMH) inhibition of Candida albicans growth in the presence of Lactobacillus and Lactococcus species

, , , &
Pages 127-134 | Received 14 Jan 2008, Published online: 11 Jul 2009

References

  • Wilson M. Microbial inhabitants of humans: their ecology and role in health and disease. Cambridge University Press, New York 2005; 206–48
  • Fernandes CF, Shahani KM, Amer MA. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiol Rev 1987; 46: 343–56
  • Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, et al. Characterisation and selection of vaginal Lactobacillus strains from the preparation of vaginal tablets. J Appl Microbiol 2002; 93: 884–93
  • Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001; 32: 37–41
  • Hamilton-Miller JMT, Shah S. Susceptibility patterns of vaginal lactobacilli to eleven oral antibiotics. J Antimicrob Chemother 1994; 33: 1059–60
  • Strus M, Kucharska A, Kukla G, Brzychczy-Wloch, Maresz K, Heczko PB. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005;13:69–75.
  • Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996; 275: 870–7
  • Maggi L, Mastromarino P, Macchia S, Brigidi P, Pirovano F, Matteuzzi D, et al. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur J Pharm Biopharm 2000; 50: 389–95
  • Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomised, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35: 131–4
  • Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001; 183S: S77–S80
  • Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23: 32–45
  • McFarland LV, Elmer GW. Pharmaceutical probiotics for the treatment of anaerobic and other infections. Anaerobe 1997; 3: 73–8
  • Bartlett JG, Onderdonk AB, Drudc E, Goldstein C, Anderka M, Alpert S, et al. Quantitative bacteriology of the vaginal flora. J Infect Dis 1977; 136: 271–7
  • Ison CA. Factors affecting the microflora of the lower genital tract of healthy women. Human microbial ecology, MJ Hill, PD Marsh. CRC Press, Boca Raton, FL 1990; 111–29
  • Cohen L. Influence of pH on vaginal discharges. Br J Vener Dis 1969; 45: 241–7
  • Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401–12
  • Al-Ghazzewi FH, Khanna S, Tester RF, Piggott J. The potential use of hydrolysed konjac glucomannan as a prebiotic. J Sci Food Agric 2007; 87: 1758–66
  • Larsen B. Vaginal flora in health and disease. Clin Obstet Gynecol 1993; 36: 107–21
  • Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991; 164: 94–100
  • McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000; 49: 543–52
  • Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotic can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30: 49–52
  • Wagner RD, Pierson C, Warne T, Dohnalek M, Farmer J, Roberts L, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997; 65: 4165–72
  • Barbes C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDs 1999; 13: 747–51
  • Boris S, Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microb Infect 2000; 2: 543–6
  • Yu K, Chien YW. Vaginal delivery and absorption of drugs. Encyclopedia of pharmaceutical technology, Vol 16, J Swarbrick, JC Boylan. Marcel Dekker, New York 1997; 153–85